Annual Drug Patent Expirations for DOPTELET
Doptelet is a drug marketed by Akarx Inc and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.
This drug has eighteen patent family members in fourteen countries.
The generic ingredient in DOPTELET is avatrombopag maleate. One supplier is listed for this compound. Additional details are available on the avatrombopag maleate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com